BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/14/2019 9:57:12 AM | Browse: 781 | Download: 1222
 |
Received |
|
2018-11-28 01:28 |
|
Peer-Review Started |
|
2018-11-28 06:00 |
|
To Make the First Decision |
|
2019-01-18 07:47 |
|
Return for Revision |
|
2019-01-18 09:24 |
|
Revised |
|
2019-01-25 14:57 |
|
Second Decision |
|
2019-01-28 09:47 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2019-01-28 19:40 |
|
Articles in Press |
|
2019-01-28 19:40 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-02-13 09:37 |
|
Publish the Manuscript Online |
|
2019-02-14 09:57 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Evolving role of magnetic resonance techniques in primary sclerosing cholangitis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Emmanuel A Selvaraj, Emma L Culver, Helen Bungay, Adam Bailey, Roger W Chapman and Michael Pavides |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Oxfordshire Health Service Research Committee (OHSRC) |
|
| National Institute of Health Research (NIHR) Biomedical Research Centre |
|
|
| Corresponding Author |
Michael Pavides, BSc, DPhil, MBBS, MRCP, Doctor, Oxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Level 0, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, United Kingdom. michael.pavlides@cardiov.ox.ac.uk |
| Key Words |
Primary sclerosing cholangitis; Magnetic resonance imaging; Magnetic resonance cholangiopancreatography; Magnetic resonance elastography; Diffusion magnetic resonance imaging; Endoscopic retrograde cholangiopancreatography |
| Core Tip |
Magnetic resonance (MR) imaging/MR cholangiopancreatography remains the cornerstone in the diagnosis and follow-up of primary sclerosing cholangitis (PSC) patients. However, heterogeneity in acquisition, image processing and interpretation varies significantly. There is ongoing interest in establishing non-invasive methods to predict clinical endpoints in PSC. A number of recent publications have focused on objectively quantifying output from various MR techniques and have suggested MR parameters as potential prognostic risk-stratification tool in PSC. Our aim is to revisit the historical use of imaging in PSC and consolidate the evolving role of the different MR techniques to date in the quest for establishing a validated imaging biomarker for PSC. |
| Publish Date |
2019-02-14 09:57 |
| Citation |
Selvaraj EA, Culver EL, Bungay H, Bailey A, Chapman RW, Pavlides M. Evolving role of magnetic resonance techniques in primary sclerosing cholangitis. World J Gastroenterol 2019; 25(6): 644-658 |
| URL |
https://www.wjgnet.com/1007-9327/full/v25/i6/644.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v25.i6.644 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
